Welcome to Sansai and Q4 report. Of report. And the for yield free testing. Disclaimer. So at Qatar, that we have that order intake.
So can we say at towards the target. 63%. The so at the half then, for selling for a a tox hub or even have the product mix for go in a from vitro screens Summon target, we have your own EBITDA for for better control guard. So So we have 43% direct for selling. We had a little lag.
A little slow on 30%. 66%. For guard skin test guideline standard test for skin sense. Defined approach. Performance test So So to say, we have test only regular tourist.
Example, L'Oreal, Clarence, for MedTech hearing aid for fertility and better commercial or engineering. Okay. There's some more hands on this. Sales pipeline sales pipeline sales pipeline We see we a positive out here for Framptet and for VitroScreen. We throw what we all at So how we do the blogs start to send.
They also the telecom and how King. So we take us on on ordering on sales pipeline So and effect testing. So performance effect method Vitro screen test platforms or some bigger organ data detecting. From regulators. Pipeline.
So significant beta therapy can accelerate and. The the ends of the guard skin dose response, then of guard skin. Dose response dose response. So the and and and medical device, DiobA v four four in and guard, some standard med tech tester. They would truly expand on the med tech test.
So how skin standard ultimate. VICTRO screens organoid platform. So now we don't med tech program or how how do we support guard skin medical device a medtech. So standard lab. So So and the normal test.
So game changer test also research institute for fragrance materials standard service. At the global uplifted mode yield free yield free testing accelerator. We have very positive signal from the SOHA and the Voron. First, from FDA, some Gurult or SAO at NurOdax technique from. Munich at this at number.
NIH. I'm a conscience NIH, National Institute for Health. So from the. Oh, Maria. So can we also And then for selling So, and for selling and and and for weld for log sales pipe pipeline sales pipe and for ViterScreen Mhmm.
Mhmm. Order So for selling with Or the So we have to for trend with first of sales pipe. Sales pipeline. So Yeah. 66% for for selling and for selling selling selling and and for for selling selling mix.
Avenue for selling. 50% Mhmm. So you're saying for Denmark. Mhmm. Mhmm.
Medical device tested. The the the ring trial for guard skin. Of of Meditech regulators, so FDA notified bodies other can you hear from me Yeah. So we we see, you know, operating for screen. Yeah.
Was. So fantastic for concern. We have little money over. My dear, so COV effect test. Toxicolgate checkpoints test.
So technique Yeah. I believe it's key opinion leaders. How does the US customs influence the business? 57%